PSMC2 Regulates Cell Cycle Progression Through the p21/Cyclin D1 Pathway and Predicts a Poor Prognosis in Human Hepatocellular Carcinoma

Yiwei Liu(The Ohio State University), Xiaofeng Wu(Chinese Academy of Medical Sciences & Peking Union Medical College)

Frontiers in Oncology

February 26, 2021

10.3389/fonc.2021.607021

Cited by 17

Related Papers

Nonhypotensive Dose of Telmisartan Attenuates Cognitive Impairment Partially Due to Peroxisome Proliferator-Activated Receptor-γ Activation in Mice With Chronic Cerebral Hypoperfusion

|Stroke|2010|128

Phosphorylated FOXQ1, a novel substrate of JNK1, inhibits sorafenib-induced ferroptosis by activating ETHE1 in hepatocellular carcinoma

|Cell Death and Disease|2024|9